The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Generic Drug Research and Development Services Market Research Report 2024
Synopsis
Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of activities and expertise aimed at obtaining regulatory approval for a generic version of a brand-name drug. The service typically includes activities such as formulation development, preclinical studies, bioequivalence testing, clinical trial design and execution, regulatory strategy development, and submission preparation. The service provider may also offer project management and regulatory affairs support throughout the development process. The goal of Generic Drug Development Service is to assist pharmaceutical companies in developing generic drugs that are equivalent to the reference product in terms of dosage form, strength, route of administration, quality, safety, and efficacy. This involves demonstrating bioequivalence through rigorous testing and analysis. By utilizing a Generic Drug Development Service, pharmaceutical companies can streamline the drug development process, reduce costs, and ensure compliance with regulatory requirements. These services can be particularly beneficial for smaller pharmaceutical companies or those with limited in-house capabilities in drug development and regulatory affairs.
Global Generic Drug Research and Development Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Generic Drug Research and Development Services market research.
Key companies engaged in the Generic Drug Research and Development Services industry include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Generic Drug Research and Development Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Generic Drug Research and Development Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Generic Drug Research and Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PDG
Navitas Life Sciences
Teva
Avivia
Aavis Pharmaceuticals
CRS
Eurofins
Veeda CRO
JOINN
Tigermed
PHARMARON
DiQi Pharmaceuticals Co, Ltd.
AUSUN PHARM
Beijing Honghui Meditech Co., Ltd.
HiCrystal
MEDICILON
Duo Rul Pharmaceutlcal Co..Ltd
TI Group
TIANHENG
BIOGINGLAM
XINYAO
HIPHAR MEDICAL
NKD PHARM CO, LTD
WuXi AppTec
Segment by Type
On-line Services
Off-line Services
Segment by Application
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Generic Drug Research and Development Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of activities and expertise aimed at obtaining regulatory approval for a generic version of a brand-name drug. The service typically includes activities such as formulation development, preclinical studies, bioequivalence testing, clinical trial design and execution, regulatory strategy development, and submission preparation. The service provider may also offer project management and regulatory affairs support throughout the development process. The goal of Generic Drug Development Service is to assist pharmaceutical companies in developing generic drugs that are equivalent to the reference product in terms of dosage form, strength, route of administration, quality, safety, and efficacy. This involves demonstrating bioequivalence through rigorous testing and analysis. By utilizing a Generic Drug Development Service, pharmaceutical companies can streamline the drug development process, reduce costs, and ensure compliance with regulatory requirements. These services can be particularly beneficial for smaller pharmaceutical companies or those with limited in-house capabilities in drug development and regulatory affairs.
Global Generic Drug Research and Development Services market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Generic Drug Research and Development Services market research.
Key companies engaged in the Generic Drug Research and Development Services industry include PDG, Navitas Life Sciences, Teva, Avivia, Aavis Pharmaceuticals, CRS, Eurofins, Veeda CRO and JOINN, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Generic Drug Research and Development Services were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Generic Drug Research and Development Services market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Generic Drug Research and Development Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
PDG
Navitas Life Sciences
Teva
Avivia
Aavis Pharmaceuticals
CRS
Eurofins
Veeda CRO
JOINN
Tigermed
PHARMARON
DiQi Pharmaceuticals Co, Ltd.
AUSUN PHARM
Beijing Honghui Meditech Co., Ltd.
HiCrystal
MEDICILON
Duo Rul Pharmaceutlcal Co..Ltd
TI Group
TIANHENG
BIOGINGLAM
XINYAO
HIPHAR MEDICAL
NKD PHARM CO, LTD
WuXi AppTec
Segment by Type
On-line Services
Off-line Services
Segment by Application
Government & Regulatory Agencies
Pharmaceutical Company
Academic Centre
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Generic Drug Research and Development Services report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Drug Research and Development Services Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 On-line Services
1.2.3 Off-line Services
1.3 Market by Application
1.3.1 Global Generic Drug Research and Development Services Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Government & Regulatory Agencies
1.3.3 Pharmaceutical Company
1.3.4 Academic Centre
1.3.5 CRO
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Drug Research and Development Services Market Perspective (2018-2029)
2.2 Generic Drug Research and Development Services Growth Trends by Region
2.2.1 Global Generic Drug Research and Development Services Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Generic Drug Research and Development Services Historic Market Size by Region (2018-2023)
2.2.3 Generic Drug Research and Development Services Forecasted Market Size by Region (2024-2029)
2.3 Generic Drug Research and Development Services Market Dynamics
2.3.1 Generic Drug Research and Development Services Industry Trends
2.3.2 Generic Drug Research and Development Services Market Drivers
2.3.3 Generic Drug Research and Development Services Market Challenges
2.3.4 Generic Drug Research and Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Drug Research and Development Services Players by Revenue
3.1.1 Global Top Generic Drug Research and Development Services Players by Revenue (2018-2023)
3.1.2 Global Generic Drug Research and Development Services Revenue Market Share by Players (2018-2023)
3.2 Global Generic Drug Research and Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Drug Research and Development Services Revenue
3.4 Global Generic Drug Research and Development Services Market Concentration Ratio
3.4.1 Global Generic Drug Research and Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Drug Research and Development Services Revenue in 2022
3.5 Generic Drug Research and Development Services Key Players Head office and Area Served
3.6 Key Players Generic Drug Research and Development Services Product Solution and Service
3.7 Date of Enter into Generic Drug Research and Development Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Drug Research and Development Services Breakdown Data by Type
4.1 Global Generic Drug Research and Development Services Historic Market Size by Type (2018-2023)
4.2 Global Generic Drug Research and Development Services Forecasted Market Size by Type (2024-2029)
5 Generic Drug Research and Development Services Breakdown Data by Application
5.1 Global Generic Drug Research and Development Services Historic Market Size by Application (2018-2023)
5.2 Global Generic Drug Research and Development Services Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Generic Drug Research and Development Services Market Size (2018-2029)
6.2 North America Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Generic Drug Research and Development Services Market Size by Country (2018-2023)
6.4 North America Generic Drug Research and Development Services Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Drug Research and Development Services Market Size (2018-2029)
7.2 Europe Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Generic Drug Research and Development Services Market Size by Country (2018-2023)
7.4 Europe Generic Drug Research and Development Services Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Drug Research and Development Services Market Size (2018-2029)
8.2 Asia-Pacific Generic Drug Research and Development Services Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2018-2023)
8.4 Asia-Pacific Generic Drug Research and Development Services Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Drug Research and Development Services Market Size (2018-2029)
9.2 Latin America Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Generic Drug Research and Development Services Market Size by Country (2018-2023)
9.4 Latin America Generic Drug Research and Development Services Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Drug Research and Development Services Market Size (2018-2029)
10.2 Middle East & Africa Generic Drug Research and Development Services Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2018-2023)
10.4 Middle East & Africa Generic Drug Research and Development Services Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PDG
11.1.1 PDG Company Detail
11.1.2 PDG Business Overview
11.1.3 PDG Generic Drug Research and Development Services Introduction
11.1.4 PDG Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.1.5 PDG Recent Development
11.2 Navitas Life Sciences
11.2.1 Navitas Life Sciences Company Detail
11.2.2 Navitas Life Sciences Business Overview
11.2.3 Navitas Life Sciences Generic Drug Research and Development Services Introduction
11.2.4 Navitas Life Sciences Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.2.5 Navitas Life Sciences Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Generic Drug Research and Development Services Introduction
11.3.4 Teva Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.3.5 Teva Recent Development
11.4 Avivia
11.4.1 Avivia Company Detail
11.4.2 Avivia Business Overview
11.4.3 Avivia Generic Drug Research and Development Services Introduction
11.4.4 Avivia Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.4.5 Avivia Recent Development
11.5 Aavis Pharmaceuticals
11.5.1 Aavis Pharmaceuticals Company Detail
11.5.2 Aavis Pharmaceuticals Business Overview
11.5.3 Aavis Pharmaceuticals Generic Drug Research and Development Services Introduction
11.5.4 Aavis Pharmaceuticals Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.5.5 Aavis Pharmaceuticals Recent Development
11.6 CRS
11.6.1 CRS Company Detail
11.6.2 CRS Business Overview
11.6.3 CRS Generic Drug Research and Development Services Introduction
11.6.4 CRS Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.6.5 CRS Recent Development
11.7 Eurofins
11.7.1 Eurofins Company Detail
11.7.2 Eurofins Business Overview
11.7.3 Eurofins Generic Drug Research and Development Services Introduction
11.7.4 Eurofins Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.7.5 Eurofins Recent Development
11.8 Veeda CRO
11.8.1 Veeda CRO Company Detail
11.8.2 Veeda CRO Business Overview
11.8.3 Veeda CRO Generic Drug Research and Development Services Introduction
11.8.4 Veeda CRO Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.8.5 Veeda CRO Recent Development
11.9 JOINN
11.9.1 JOINN Company Detail
11.9.2 JOINN Business Overview
11.9.3 JOINN Generic Drug Research and Development Services Introduction
11.9.4 JOINN Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.9.5 JOINN Recent Development
11.10 Tigermed
11.10.1 Tigermed Company Detail
11.10.2 Tigermed Business Overview
11.10.3 Tigermed Generic Drug Research and Development Services Introduction
11.10.4 Tigermed Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.10.5 Tigermed Recent Development
11.11 PHARMARON
11.11.1 PHARMARON Company Detail
11.11.2 PHARMARON Business Overview
11.11.3 PHARMARON Generic Drug Research and Development Services Introduction
11.11.4 PHARMARON Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.11.5 PHARMARON Recent Development
11.12 DiQi Pharmaceuticals Co, Ltd.
11.12.1 DiQi Pharmaceuticals Co, Ltd. Company Detail
11.12.2 DiQi Pharmaceuticals Co, Ltd. Business Overview
11.12.3 DiQi Pharmaceuticals Co, Ltd. Generic Drug Research and Development Services Introduction
11.12.4 DiQi Pharmaceuticals Co, Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.12.5 DiQi Pharmaceuticals Co, Ltd. Recent Development
11.13 AUSUN PHARM
11.13.1 AUSUN PHARM Company Detail
11.13.2 AUSUN PHARM Business Overview
11.13.3 AUSUN PHARM Generic Drug Research and Development Services Introduction
11.13.4 AUSUN PHARM Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.13.5 AUSUN PHARM Recent Development
11.14 Beijing Honghui Meditech Co., Ltd.
11.14.1 Beijing Honghui Meditech Co., Ltd. Company Detail
11.14.2 Beijing Honghui Meditech Co., Ltd. Business Overview
11.14.3 Beijing Honghui Meditech Co., Ltd. Generic Drug Research and Development Services Introduction
11.14.4 Beijing Honghui Meditech Co., Ltd. Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.14.5 Beijing Honghui Meditech Co., Ltd. Recent Development
11.15 HiCrystal
11.15.1 HiCrystal Company Detail
11.15.2 HiCrystal Business Overview
11.15.3 HiCrystal Generic Drug Research and Development Services Introduction
11.15.4 HiCrystal Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.15.5 HiCrystal Recent Development
11.16 MEDICILON
11.16.1 MEDICILON Company Detail
11.16.2 MEDICILON Business Overview
11.16.3 MEDICILON Generic Drug Research and Development Services Introduction
11.16.4 MEDICILON Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.16.5 MEDICILON Recent Development
11.17 Duo Rul Pharmaceutlcal Co..Ltd
11.17.1 Duo Rul Pharmaceutlcal Co..Ltd Company Detail
11.17.2 Duo Rul Pharmaceutlcal Co..Ltd Business Overview
11.17.3 Duo Rul Pharmaceutlcal Co..Ltd Generic Drug Research and Development Services Introduction
11.17.4 Duo Rul Pharmaceutlcal Co..Ltd Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.17.5 Duo Rul Pharmaceutlcal Co..Ltd Recent Development
11.18 TI Group
11.18.1 TI Group Company Detail
11.18.2 TI Group Business Overview
11.18.3 TI Group Generic Drug Research and Development Services Introduction
11.18.4 TI Group Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.18.5 TI Group Recent Development
11.19 TIANHENG
11.19.1 TIANHENG Company Detail
11.19.2 TIANHENG Business Overview
11.19.3 TIANHENG Generic Drug Research and Development Services Introduction
11.19.4 TIANHENG Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.19.5 TIANHENG Recent Development
11.20 BIOGINGLAM
11.20.1 BIOGINGLAM Company Detail
11.20.2 BIOGINGLAM Business Overview
11.20.3 BIOGINGLAM Generic Drug Research and Development Services Introduction
11.20.4 BIOGINGLAM Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.20.5 BIOGINGLAM Recent Development
11.21 XINYAO
11.21.1 XINYAO Company Detail
11.21.2 XINYAO Business Overview
11.21.3 XINYAO Generic Drug Research and Development Services Introduction
11.21.4 XINYAO Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.21.5 XINYAO Recent Development
11.22 HIPHAR MEDICAL
11.22.1 HIPHAR MEDICAL Company Detail
11.22.2 HIPHAR MEDICAL Business Overview
11.22.3 HIPHAR MEDICAL Generic Drug Research and Development Services Introduction
11.22.4 HIPHAR MEDICAL Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.22.5 HIPHAR MEDICAL Recent Development
11.23 NKD PHARM CO, LTD
11.23.1 NKD PHARM CO, LTD Company Detail
11.23.2 NKD PHARM CO, LTD Business Overview
11.23.3 NKD PHARM CO, LTD Generic Drug Research and Development Services Introduction
11.23.4 NKD PHARM CO, LTD Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.23.5 NKD PHARM CO, LTD Recent Development
11.24 WuXi AppTec
11.24.1 WuXi AppTec Company Detail
11.24.2 WuXi AppTec Business Overview
11.24.3 WuXi AppTec Generic Drug Research and Development Services Introduction
11.24.4 WuXi AppTec Revenue in Generic Drug Research and Development Services Business (2018-2023)
11.24.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
